Icu Medical Stock Price To Book

ICUI Stock

USD 97.40 2.56 2.70%

ICU Medical fundamentals help investors to digest information that contributes to ICU Medical's financial success or failures. It also enables traders to predict the movement of ICU Stock. The fundamental analysis module provides a way to measure ICU Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ICU Medical stock.

Other Current Liab Total Assets

The current Price To Book Ratio is estimated to decrease to 1.08.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

ICU Medical Company Price To Book Analysis

ICU Medical's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

P/B

MV Per Share

BV Per Share

More About Price To Book | All Equity Analysis

Current ICU Medical Price To Book

1.13 X

Most of ICU Medical's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ICU Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

ICU Price To Book Driver Correlations

Understanding the fundamental principles of building solid financial models for ICU Medical is extremely important. It helps to project a fair market value of ICU Stock properly, considering its historical fundamentals such as Price To Book. Since ICU Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of ICU Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of ICU Medical's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Short Term Investments	Common Stock	Treasury Stock	Property Plant Equipment	Net Tangible Assets	Current Deferred Revenue	Good Will	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Net Invested Capital	Net Working Capital	Short Term Debt	Capital Stock	Short Long Term Debt
Total Assets		0.94	0.87	0.78	0.92	0.73	0.97	0.9	0.98	-0.36	0.73	0.34	0.96	-0.48	0.96	0.93	0.84	0.03	-0.52	0.89	0.7	0.83	0.96	0.71
Total Stockholder Equity	0.94		0.67	0.93	0.92	0.82	0.83	0.99	0.87	-0.36	0.86	0.44	0.98	-0.17	0.84	0.77	0.96	-0.21	-0.51	0.76	0.74	0.69	0.82	0.59
Net Debt	0.87	0.67		0.4	0.72	0.43	0.97	0.58	0.94	-0.32	0.37	0.1	0.75	-0.83	0.94	0.98	0.51	0.4	-0.44	0.89	0.48	0.9	0.96	0.76
Retained Earnings	0.78	0.93	0.4		0.79	0.75	0.61	0.95	0.67	-0.23	0.9	0.45	0.85	0.11	0.65	0.54	0.89	-0.41	-0.32	0.57	0.73	0.46	0.62	0.39
Accounts Payable	0.92	0.92	0.72	0.79		0.89	0.85	0.91	0.88	-0.41	0.81	0.36	0.93	-0.26	0.81	0.78	0.89	-0.05	-0.65	0.79	0.56	0.6	0.8	0.47
Net Receivables	0.73	0.82	0.43	0.75	0.89		0.6	0.85	0.64	-0.38	0.83	0.37	0.81	0.03	0.53	0.5	0.87	-0.27	-0.47	0.52	0.33	0.36	0.52	0.28
Total Liab	0.97	0.83	0.97	0.61	0.85	0.6		0.76	0.99	-0.32	0.57	0.24	0.87	-0.69	0.98	0.99	0.68	0.21	-0.49	0.92	0.6	0.89	0.99	0.74
Total Current Assets	0.9	0.99	0.58	0.95	0.91	0.85	0.76		0.81	-0.3	0.9	0.48	0.95	-0.08	0.77	0.7	0.95	-0.33	-0.45	0.69	0.7	0.61	0.75	0.52
Intangible Assets	0.98	0.87	0.94	0.67	0.88	0.64	0.99	0.81		-0.35	0.63	0.27	0.9	-0.62	0.98	0.98	0.74	0.17	-0.52	0.92	0.64	0.86	0.99	0.71
Short Term Investments	-0.36	-0.36	-0.32	-0.23	-0.41	-0.38	-0.32	-0.3	-0.35		-0.28	-0.01	-0.44	0.06	-0.32	-0.28	-0.43	-0.17	0.38	-0.3	-0.32	-0.25	-0.32	-0.22
Common Stock	0.73	0.86	0.37	0.9	0.81	0.83	0.57	0.9	0.63	-0.28		0.37	0.79	0.09	0.57	0.49	0.84	-0.29	-0.31	0.65	0.52	0.35	0.55	0.33
Treasury Stock	0.34	0.44	0.1	0.45	0.36	0.37	0.24	0.48	0.27	-0.01	0.37		0.37	0.15	0.24	0.21	0.46	-0.7	-0.3	0.22	0.26	0.17	0.23	0.15
Property Plant Equipment	0.96	0.98	0.75	0.85	0.93	0.81	0.87	0.95	0.9	-0.44	0.79	0.37		-0.27	0.87	0.82	0.95	-0.09	-0.58	0.78	0.71	0.76	0.86	0.67
Net Tangible Assets	-0.48	-0.17	-0.83	0.11	-0.26	0.03	-0.69	-0.08	-0.62	0.06	0.09	0.15	-0.27		-0.64	-0.75	0.04	-0.61	0.11	-0.63	-0.07	-0.71	-0.67	-0.6
Current Deferred Revenue	0.96	0.84	0.94	0.65	0.81	0.53	0.98	0.77	0.98	-0.32	0.57	0.24	0.87	-0.64		0.98	0.69	0.2	-0.5	0.91	0.71	0.9	1.0	0.76
Good Will	0.93	0.77	0.98	0.54	0.78	0.5	0.99	0.7	0.98	-0.28	0.49	0.21	0.82	-0.75	0.98		0.61	0.26	-0.45	0.91	0.58	0.92	0.99	0.78
Capital Surpluse	0.84	0.96	0.51	0.89	0.89	0.87	0.68	0.95	0.74	-0.43	0.84	0.46	0.95	0.04	0.69	0.61		-0.31	-0.59	0.6	0.69	0.56	0.67	0.5
Deferred Long Term Liab	0.03	-0.21	0.4	-0.41	-0.05	-0.27	0.21	-0.33	0.17	-0.17	-0.29	-0.7	-0.09	-0.61	0.2	0.26	-0.31		-0.07	0.3	-0.08	0.19	0.23	0.15
Long Term Investments	-0.52	-0.51	-0.44	-0.32	-0.65	-0.47	-0.49	-0.45	-0.52	0.38	-0.31	-0.3	-0.58	0.11	-0.5	-0.45	-0.59	-0.07		-0.46	-0.39	-0.38	-0.48	-0.34
Net Invested Capital	0.89	0.76	0.89	0.57	0.79	0.52	0.92	0.69	0.92	-0.3	0.65	0.22	0.78	-0.63	0.91	0.91	0.6	0.3	-0.46		0.56	0.75	0.93	0.66
Net Working Capital	0.7	0.74	0.48	0.73	0.56	0.33	0.6	0.7	0.64	-0.32	0.52	0.26	0.71	-0.07	0.71	0.58	0.69	-0.08	-0.39	0.56		0.55	0.68	0.46
Short Term Debt	0.83	0.69	0.9	0.46	0.6	0.36	0.89	0.61	0.86	-0.25	0.35	0.17	0.76	-0.71	0.9	0.92	0.56	0.19	-0.38	0.75	0.55		0.9	0.95
Capital Stock	0.96	0.82	0.96	0.62	0.8	0.52	0.99	0.75	0.99	-0.32	0.55	0.23	0.86	-0.67	1.0	0.99	0.67	0.23	-0.48	0.93	0.68	0.9		0.77
Short Long Term Debt	0.71	0.59	0.76	0.39	0.47	0.28	0.74	0.52	0.71	-0.22	0.33	0.15	0.67	-0.6	0.76	0.78	0.5	0.15	-0.34	0.66	0.46	0.95	0.77

Click cells to compare fundamentals

ICU Price To Book Historical Pattern

Today, most investors in ICU Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various ICU Medical's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to book growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of ICU Medical price to book as a starting point in their analysis.

ICU Medical Price To Book

Timeline

Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.

Competition

Predict ICU Medical

Price Book Value Ratio Over Time

ICU Book Value Per Share

Book Value Per Share

92.55

As of now, ICU Medical's Book Value Per Share is increasing as compared to previous years.

Based on the latest financial disclosure, ICU Medical has a Price To Book of 1.1279 times. This is 95.61% lower than that of the Health Care Equipment & Supplies sector and 82.35% lower than that of the Health Care industry. The price to book for all United States stocks is 88.14% higher than that of the company.

ICU Price To Book Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ICU Medical's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ICU Medical could also be used in its relative valuation, which is a method of valuing ICU Medical by comparing valuation metrics of similar companies.

ICU Medical is currently under evaluation in price to book category among related companies.

ICU Fundamentals

	Return On Equity	-0.0141
	Return On Asset	0.0067
	Profit Margin	(0.01) %
	Operating Margin	(0.01) %
	Current Valuation	3.72 B
	Shares Outstanding	24.37 M
	Shares Owned By Insiders	12.86 %
	Shares Owned By Institutions	89.91 %
	Number Of Shares Shorted	1.2 M
	Price To Earning	38.71 X
	Price To Book	1.13 X
	Price To Sales	1.06 X
	Revenue	2.26 B
	Gross Profit	697.76 M
	EBITDA	290.37 M
	Net Income	(29.66 M)
	Cash And Equivalents	285.59 M
	Cash Per Share	11.95 X
	Total Debt	1.7 B
	Debt To Equity	0.84 %
	Current Ratio	2.45 X
	Book Value Per Share	87.96 X
	Cash Flow From Operations	166.2 M
	Short Ratio	4.88 X
	Earnings Per Share	(1.23) X
	Price To Earnings To Growth	0.99 X
	Target Price	136.0
	Number Of Employees	14 K
	Beta	0.71
	Market Capitalization	2.31 B
	Total Asset	4.38 B
	Retained Earnings	807.85 M
	Working Capital	739.43 M
	Current Asset	505.01 M
	Current Liabilities	42.62 M
	Net Asset	4.38 B

About ICU Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze ICU Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ICU Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ICU Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether ICU Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ICU Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Icu Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Icu Medical Stock:

How To Invest In ICU

Details

Is ICU Stock a good investment?

Details

What is ICU Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out ICU Medical Piotroski F Score and ICU Medical Altman Z Score analysis.

For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.

You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Complementary Tools for ICU Stock analysis

When running ICU Medical's price analysis, check to measure ICU Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICU Medical is operating at the current time. Most of ICU Medical's value examination focuses on studying past and present price action to predict the probability of ICU Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICU Medical's price. Additionally, you may evaluate how the addition of ICU Medical to your portfolios can decrease your overall portfolio volatility.

	Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Volatility Analysis Get historical volatility and risk analysis based on latest market data
	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA
	Bonds Directory Find actively traded corporate debentures issued by US companies
	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
	Commodity Channel Use Commodity Channel Index to analyze current equity momentum

Is ICU Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICU Medical. If investors know ICU will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICU Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.24)

Earnings Share

(1.23)

Revenue Per Share

93.775

Quarterly Revenue Growth

0.017

Return On Assets

0.0067

The market value of ICU Medical is measured differently than its book value, which is the value of ICU that is recorded on the company's balance sheet. Investors also form their own opinion of ICU Medical's value that differs from its market value or its book value, called intrinsic value, which is ICU Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICU Medical's market value can be influenced by many factors that don't directly affect ICU Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between ICU Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICU Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICU Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Icu Medical Stock Price To Book

ICU Medical Company Price To Book Analysis

P/B

MV Per Share

BV Per Share

Current ICU Medical Price To Book

ICU Price To Book Driver Correlations

ICU Price To Book Historical Pattern

ICU Book Value Per Share

Book Value Per Share

92.55

ICU Price To Book Peer Comparison

ICU Fundamentals

About ICU Medical Fundamental Analysis

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for ICU Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY